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Summary. Objective: A quality improvement (QI) strategy to improve the rate of genetic
counseling (GC) services was initiated in cystic fibrosis (CF) care Center E in 2010. This state-
wide study was conducted to determine: (1) GC rates before and after implementation of the
QI strategy at Center E; (2) characteristics associated with not receiving GC; and (3) topic
areas addressed during GC. Methods: The retrospective study included 1,097 CF carriers born
from 2008 to 2011 identified through Michigan’s Newborn Screening Program. Rate of GC
services was determined for Center E and the other four CF centers before and after the QI
change. Bivariate and multivariable logistic regression was used to determine associations
between select characteristics and not receiving GC. Topic areas discussed during GC ses-
sions were assessed using frequency tables. Results: Rate of GC services in Center E in-
creased from 23% in 2008–2010 to 91% in 2011, while at the other centers approximately 92%
received GC services across those years. In 2008–2010, being seen at Center E and black
race were significantly associated with increased likelihood of not receiving GC services in
adjusted analyses. In 2011, neither characteristic was associated with receipt of GC. Of 16
target topic areas, all were discussed in 85% of GC sessions. Conclusions: Implementing a QI
strategy of providing sweat test results at the GC appointment within Center E resulted in more
CF carriers receiving comprehensive GC services. Center-specific procedure differences
should be assessed to increase rate of GC services following a positive CF newborn screen.
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INTRODUCTION
Michigan’s Newborn Screening (MI-NBS) Program
provides an infrastructure for identification of >50 seri-
ous disorders in infants and management through adult-
hood. Cystic fibrosis (CF) was added to MI-NBS in
2007. In conjunction with its implementation, MI-NBS
established a CF NBS Advisory Board for quality as-
surance and to pursue research endeavors. It was also
established to ensure quality and consistent patient care
following a positive NBS. The board is comprised of
CF Foundation accredited (CFF) Center Directors, ge-
netic counselors, Department of Community Health
Laboratory and NBS Follow-up Program staff, and
parents.
CF NBS is currently available in all 50 states and the
District of Columbia1 through a variety of methodolo-
gies. MI-NBS employs a two-tiered immunoreactive
trypsinogen (IRT)/DNA algorithm. A positive screen
occurs when one or two CF transmembrane conduc-
tance regulator (CFTR) mutations are detected follow-
ing an initial elevated IRT value. The majority of
newborns identified are clinically healthy CF carriers.
In accordance with the CDC recommendation,2
MI-NBS has established an algorithm to provide genet-
ic counseling (GC) services to all parents of newborns
scheduled for sweat testing following a positive CF
NBS. For parental convenience, the counseling is usual-
ly done the same day the sweat testing is performed.
GC provides information and support to individuals
coping with the risk or reality of genetic disorders in
their children. Previous studies have shown multiple
benefits of GC to families of children following CF
NBS. Farrell et al.3 concluded that counseling provided
by genetic counselors, pediatric pulmonologists, or
nurse specialists was superior to counseling provided
by primary care physicians. Parents also prefer receiv-
ing information regarding CF NBS from knowledgeable
and sensitive specialists.4,5 Not only is GC for CF NBS
preferred and appreciated by patients, it has also been
shown to increase parental knowledge and understand-
ing and reduce anxiety.5–7 The goal of GC in MI NBS
is to: (1) delineate carrier status versus disease status,
(2) discuss the differences between CFTR-related meta-
bolic syndrome and CF, (3) decrease parental anxiety,
and (4) discuss and provide carrier testing and precon-
ception planning to parents.
In 2010, the CF NBS Advisory Board recognized a
significant disparity in rate of GC services provided by
one particular CFF center (Center E) when compared to
the state’s other four CFF centers (Centers A–D). It was
unknown whether certain demographic factors unique
to that CFF center’s population, logistical barriers, or a
combination were contributing to the observed dispro-
portionate number of parents not receiving GC at that
center. This study was conducted to retrospectively
evaluate the rate of GC services received by CF carriers
identified through NBS and characteristics associated
with not receiving counseling before and after imple-
mentation of a QI strategy within Center E. In addition,
we assessed topic areas addressed during GC sessions
to ensure consistency of quality information provision.
This study attempts to identify and reduce any existing
barriers to GC for CF NBS and increase efficiency of
GC in the future.
MATERIALS AND METHODS
MI-NBS is conducted using blood spots collected at
birth from infants. Samples with IRT concentrations
>96th daily percentile undergo a 40-panel CFTR DNA
mutation analysis. Infants with at least one mutation are
considered positive for CF NBS and are referred to a
CFF Accredited Center for confirmatory sweat testing.
Between October 2007 and February 2009, infants with
no mutations but IRT concentrations >99.8th percentile
were also sent for confirmatory testing.
Families are provided an opportunity for GC on the
day of confirmatory sweat testing. In four of Michigan’s
CFF centers, GC is provided by certified, or active can-
didate status, genetic counselors. In the remaining cen-
ter, GC is provided by a physician, either the CF center
Director or Associate Director. When parents present
for sweat testing in Centers A–D, these centers either
require GC in order to receive sweat test results or es-
cort the parents to GC after receiving the results of
sweat testing. Center E released the sweat test results to
parents before attending the GC clinic visit, which is in
a different building. In 2010, Center E implemented a
change in policy requiring families receive sweat test
results from a genetic counselor at the GC clinic
appointment.
Center E took several steps to prepare families for
the policy change. When families call to schedule the
sweat testing appointment, Center E staff informs them
that they will meet with several different providers dur-
ing the visit and should allow for a lengthy visit. When
parents arrive at the sweat test appointment, they are
given a written welcome packet which lists all the steps
taken during the visit, explains the sweat testing proce-
dure, describes the need for GC on the same day as the
sweat test, tells them the genetic counselor will provide
ABBREVIATIONS:
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the sweat test results, and states the time of the GC
appointment. This packet also contains walking direc-
tions to the GC appointment.
Following GC at all centers, the genetic counselor or
CFF center Director completes and submits a standard
form with parent demographics, sweat testing results,
and key topic areas discussed (from a checklist of 16
benchmarks) to the MI-NBS Program (form available
upon request). This form also contains an area to record
whether parents refused or failed to attend the GC
session.
The study population included infants born between
January 1, 2008 and December 31, 2011, identified as
positive for CF NBS, and confirmed as CF carriers.
Infants whose GC status could not be determined, who
received confirmatory testing outside of Michigan, or
who received confirmatory testing in-state but not at
one of the CFF centers were excluded from analyses.
Data analysis was performed using SAS version 9.2
(SAS Institute, Inc., Cary, NC). Characteristics exam-
ined included: birth weight, gestational age, race, neo-
natal intensive care unit (NICU) admission, maternal
age, maternal education, birth year, and CFF center.
Since 2007, the linkage of MI-NBS and live births
records has been conducted to identify potentially un-
screened infants and has a match rate of >99%.8 Since
demographic and perinatal characteristics on birth cer-
tificates tend to be more accurately and consistently
recorded, we used characteristics from the linked birth
certificates instead of from the NBS cards. If a record
could not be matched to the birth certificate, character-
istics were taken from the NBS card. Gestational age
and birth weight were dichotomized into pre-term birth
(<37 weeks gestation) and low birth weight
(<2,500 g). Race was categorized as white, black, and
other. Maternal age at time of birth was calculated from
the mother’s and infant’s birth dates and divided into
<25, 25–29, 30–34, and 35 years old. Maternal edu-
cation at time of birth was divided into <high school,
completed high school or equivalent, and >high school.
Birth years 2008–2010 were collapsed into one group
to compare the GC rates before and after implementa-
tion of the policy change at Center E. The CFF center
responsible for confirmatory testing and GC was re-
trieved from the NBS follow-up database. Centers A–D
were combined into one group to compare the GC rate
for those centers with Center E’s rate.
The rate of GC uptake was determined for Centers
A–D and Center E for the years before and after the
procedural change at Center E. Bivariate and multivari-
able analyses assessing predictors of not receiving GC
were conducted pre- and post-change at Center E. After
restricting to those who received or refused counseling
as noted on the standard form submitted to the NBS
Follow-up Program, bivariate, and multivariable
analyses were repeated to assess predictors of refusing
counseling. The topic areas discussed during each GC
session were assessed using frequency tables. An alpha
of 0.05 was used for this study.
RESULTS
Overall, 460,788 infants born from 2008 to 2011 in
Michigan were screened for CF and 1,124 were identi-
fied as CF carriers. Twenty-seven CF carriers were ex-
cluded from analyses because they were seen at CFF
centers outside Michigan (n ¼ 17), at non-CFF centers
in Michigan (n ¼ 7), or their GC status could not be
determined (n ¼ 3). Characteristics did not significantly
differ between children seen at CFF centers in Michi-
gan and those excluded from the study.
NBS records were linked to birth certificates for
1,095 of the 1,097 children included in the study
(99.8%). Demographic and perinatal characteristics for
the study population are presented in Table I. One-third
of the study population was seen at Center E.
TABLE I—Demographic and Perinatal Characteristics of
























<High school 154 14.1
High school 317 29.1
>High school 619 56.8
CFF center
Centers A–D 725 66.1





Excludes those seen outside Michigan (17), seen at non-CFF centers
in Michigan (7), and with unknown genetic counseling status (3).
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The rate of GC services received was determined by
CFF center and birth year category for the 1,097 chil-
dren who were seen at CFF centers in Michigan with
known GC status (Table II). For birth years 2008–2010,
approximately 90% of CF carriers seen at Centers A–D
(range, 85–93%) received GC compared to 23% of
those seen at Center E. Overall, 68% of CF carriers
born during these years received GC. In 2011, 94% of
CF carriers seen at Centers A–D (range, 88–100%) and
91% of CF carriers seen at Center E received GC. The
group who did not receive GC included active refusals
(n ¼ 221), passive refusals through failure to attend GC
appointment (n ¼ 24), and missed due to some other
reason (n ¼ 49).
Table III presents bivariate results for birth years sep-
arated into before implementation of the procedural
change at Center E (2008–2010) and after (2011). For
years 2008–2010, black race, maternal education <high
school, and being seen at Center E were significantly
associated with increased odds of not receiving GC in
bivariate analyses, with being seen at Center E having
the strongest association (OR ¼ 29.5, 95% CI: 20.0,
43.4). After adjusting for race, maternal education, and
CFF center, only CFF center (OR ¼ 24.3, 95% CI: 16.0,




Received GC Did not receive GC Received GC Did not receive GC
N % N % N % N %
Centers A–D 522 89.5 61 10.5 134 94.4 8 5.6
Center E 63 22.5 217 77.5 84 91.3 8 8.7
Summary 585 67.8 278 32.2 218 93.2 16 6.8
Did not receive GC includes no shows (24), active refusals (221), and other (49).
TABLE III—Unadjusted Associations Between Select Characteristics and no Genetic Counseling Receipt Among CF
Carriers, by Time Period, Michigan
Characteristic
2008–2010 2011
OR 95% CI OR 95% CI
Birth weight (g)
<2,500 1.4 (0.8, 2.2) 5.7 (1.6, 20.4)
2,500þ 1.0 1.0
Gestational age (weeks)
<37 1.5 (0.9, 2.3) 6.6 (2.0, 21.7)
37þ 1.0 1.0
NICU




Black 5.8 (3.9, 8.5) 2.3 (0.7, 7.9)
Other 1.1 (0.4, 3.2) 1 1
Maternal age (years)
<25 1.0 (0.7, 1.4) 0.7 (0.2, 2.5)
25–29 1.0 (0.7, 1.5) 0.3 (0.1, 1.8)
30–34 1.0 1.0
35þ 0.9 (0.6, 1.6) 1.3 (0.3, 6.0)
Maternal education
<High school 1.7 (1.1, 2.6) 1.4 (0.4, 5.3)
High school 1.1 (0.8, 1.6) 0.7 (0.2, 2.7)
>High school 1.0 1.0
CFF center
Centers A–D 1.0 1.0
Center E 29.5 (20.0, 43.4) 1.6 (0.6, 4.4)
1Unstable model.
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37.1) and race (OR ¼ 1.7, 95% CI: 1.0, 2.9) were sig-
nificantly associated with lack of GC (data not shown).
For birth year 2011, low birth weight, pre-term birth,
and being admitted to the NICU were significantly as-
sociated with increased likelihood of not receiving GC.
Being seen at Center E and black race were not signifi-
cantly associated with GC services received in 2011.
After excluding CF carriers who did not show up for
the scheduled GC appointment or did not receive
counseling for some other reason, the bivariate associa-
tions between characteristics and refusing GC were de-
termined. The associations were similar to those
assessing failure to receive GC for any reason. For birth
years 2008–2010, black race, maternal educa-
tion < high school, and being seen at Center E were all
significantly associated with increased likelihood of re-
fusing GC in unadjusted models (data not shown). After
adjustment, only being seen at Center E remained sig-
nificantly associated with refusal. For birth year 2011,
pre-term birth and NICU admission were significantly
associated with GC refusal in bivariate models.
Of the 803 CF carriers who received GC, information
was recorded on the GC form for 795 children (99%).
Mothers were present for 90% of the sessions and
fathers for 70%. Two family members attended the
counseling session for nearly three-quarters of the car-
riers (71%). The 16 content area items included in the
GC form were covered in nearly all of the sessions
(Table IV). Discussion of gene sequencing took place
in 91% of sessions, with all other topic areas discussed
in more than 97% of sessions. All 16 items were dis-
cussed in 85% of sessions.
DISCUSSION
GC has been recommended as part of NBS programs
for many diseases including CF.2,3 The current literature
on CF NBS establishes the benefits of GC from both
the parents’ and providers’ perspective. Almost all of
the reported studies have relied upon parental report fo-
cusing on methods of communication, recall of infor-
mation by parents and types of information given to
parents.4–7 GC was found to be very effective in im-
proving parental knowledge about carrier status of the
parents and their children, presence or absence of dis-
ease in the screened child, risk of having future children
with CF, and future family planning decisions.9 Howev-
er, although there is a reduction in parental anxiety
about abnormal CF NBS test with GC, many parents
were still confused about the newborn’s carrier status
and concept of residual risk even after GC.5
While assessing parental viewpoints of GC in CF
NBS is certainly helpful, further assessment of GC
efficacy and topic areas addressed is needed using
reports from physicians and genetic counselors. MI-
NBS requires submission of GC reporting forms de-
veloped by MI genetic counselors to ensure those pro-
viding GC uphold practice based competencies
established by the American Board of Genetic
Counseling.10 This standardized approach ensures all
parents are afforded consistent comprehensive infor-
mation, and collected information is reviewed by the
CF NBS Advisory board to encourage compliance
with benchmarks established for optimal service. Six-
teen benchmarks are included on the GC form and
ensure the genetic counselor obtains a three genera-
tion pedigree with targeted CF questions; assesses
psychosocial needs; discusses basic genetic concepts
(autosomal recessive inheritance); explains implica-
tions of carrier results for the child, parents and ex-
tended family members; offers parental carrier
screening and provides written educational informa-
tion. In all five CFF centers, nearly all 16 benchmarks
were achieved, providing high degree of consistency
of GC services between CFF centers in the State of
Michigan CF NBS program. Thus, the most critical
component to receipt of comprehensive GC services
in Michigan is ensuring that parents of CF carriers
attend the GC appointment.
Overall, there has been limited literature evaluating
variables influencing the rate of GC services that assess
impact of both potential logistical barriers and demo-
graphic factors. Our study assessed the rate of GC in
different CFF centers across the state to identify and
potentially eliminate barriers to GC. Centers A–D either
have always required GC in order to receive sweat test
results or escorted parents to GC after receiving the
results of sweat testing which has led to the greatest
TABLE IV—Summary of Genetic Counseling Information






















Form available upon request.
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receipt of GC services, while Center E had significantly
reduced compliance with GC during 2008–2010 proba-
bly due to lack of parental understanding of the impor-
tance of GC or logistical barriers. Following a change
of policy in Center E to require parents obtain GC in
order to receive sweat test results, there were similar
acceptance rates of GC services among all five CFF
centers in 2011, with 93% of parents of CF carriers
receiving GC.
The change in the rate of GC services seen in Center
E is in agreement with Comeau et al.11 who reported
the results of three models of post-screening communi-
cation with families at five CF centers in Massachusetts.
The authors found 95% compliance with sweat testing
but a wide variability with completion of GC (32–
90%). Families who were escorted to GC at the same
day of sweat chloride testing were more likely to have
GC (84–90%) than those who scheduled GC indepen-
dently of the sweat test and usually at a different date
(32%).
Although not addressing the rate of GC directly,
Lagoe et al.12 evaluated the rate of parental CF carrier
screening by randomizing families into two groups; one
having GC on the same day as the sweat test (referred
to as Special Care) versus reporting sweat test results
via phone by a pediatrician who may have recom-
mended GC at a later date (referred to as standard
care). Fifty percent (17/34) of the parents who were
managed via special care had parental CF carrier
screening versus 22% (6/27) of the parents who were
managed via standard care approach. The authors con-
cluded that offering GC and carrier genetic testing
increases probability of parental consent to further iden-
tification of their carrier status and may facilitate fur-
ther dissemination of such knowledge and testing
among relatives.
Our study highlights the importance of comparing
center-specific differences when assessing the rate of
GC services. Without this, black race would have been
most significantly associated with not receiving GC in
unadjusted and adjusted analyses during years 2008–
2010. Since 36% of Center E’s patient population was
black compared to 4–11% of Center A–D’s populations,
the significant finding for black race was most likely a
spurious association. Center E’s initial policies for GC
services had more influence on rate of GC than race.
Thus, the center-specific procedures affected GC rates
more than demographic characteristics. To ensure the
highest rate of GC, each CFF center should evaluate the
rate of GC for CF NBS cases and its policies for pro-
viding sweat test results.
Tracking when procedural changes are implemented
is critical for assessing the effect of those changes and
associations before and after implementation. Our study
found that the GC rates among CF carriers statewide
increased from 68% for 2008–2010 to 93% in 2011,
largely driven by Center E’s rate improving from 23%
to 91%. After repeating the bivariate analyses for all
years combined (2008–2011), the following variables
were significantly associated with lack of GC receipt:
low birth weight, pre-term birth, NICU admission,
black race, and maternal education < high school. The
separate analyses for the years before and after imple-
mentation of the quality improvement project at Center
E indicated that black race and maternal education
were associated with reduced GC receipt before imple-
mentation. The perinatal health complications such as
low birth weight, pre-term birth, and NICU admission
were associated with reduced GC receipt after imple-
mentation. Potential precarious health status of these
infants may impact parental uptake of GC, but these
results should be interpreted with caution since only 16
CF carriers born in 2011 did not receive GC.
Our study provides additional information regarding
both the type of information provided in a CF NBS GC
session as well as factors that impact the rate of GC for
CF carriers identified through NBS. We have shown
that families in the State of Michigan receive GC ser-
vices in a uniform manner and highlight the importance
of an advisory board in program evaluation and im-
provement. As seen in other studies, we show further
evidence that the best service delivery model is one that
offers GC on the same day as the sweat test in a NBS
population. Unlike previous studies, however, we dem-
onstrate that just offering GC on the same day as the
sweat test may not be enough to ensure that families
receive these services. Parents who are worried primari-
ly about their child being affected with CF may not
consider GC a priority at the time of the sweat test. If
they receive negative sweat test results before receiving
counseling, they may not have full understanding of the
importance of GC, may not be concerned about future
family planning given the recent birth of a baby, or sim-
ply may not have been educated about the time needed
for the two appointments on the same day. This may
cause them to defer having GC on the day of the
appointment if given a choice and fail to follow up at a
later date after receiving the reassurance of a negative
sweat test result. This may ultimately suggest that more
pre-sweat test education is needed regarding the bene-
fits of GC in the CF NBS population.
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